Ying Li
Experienced in EGFR Positive Lung Cancer

Dr. Ying Li

Radiation Oncology
2946 East Banner Gateway Drive, 
Gilbert, AZ 
Accepting New Patients
Offers Telehealth
Experienced in EGFR Positive Lung Cancer
2946 East Banner Gateway Drive, 
Gilbert, AZ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Ying Li is a Radiation Oncologist in Gilbert, Arizona. Dr. Li is rated as an Experienced provider by MediFind in the treatment of EGFR Positive Lung Cancer. Her top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Non-Small Cell Lung Cancer (NSCLC), and Squamous Cell Lung Carcinoma. Dr. Li is currently accepting new patients.

Her clinical research consists of co-authoring 5 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Peking University, 1997
Residency
State University of New York College at Buffalo, Radiation Oncology, 2008
Specialties
Radiation Oncology
Licenses
Radiology in TX
Board Certifications
American Board Of Radiology
Hospital Affiliations
Banner - University Medical Center Phoenix
Banner Gateway Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 2 Less Insurance Carriers -

Locations

Banner MD Anderson Cancer Center at Banner Gateway Medical Center
2946 East Banner Gateway Drive, Gilbert, AZ 85234
Other Locations
Banner MD Anderson Cancer Center at Banner University Medical Center - Phoenix
925 East McDowell Road, Phoenix, AZ 85006

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Enrollment Status: Active_not_recruiting
Publish Date: November 25, 2025
Intervention Type: Radiation, Drug
Study Drugs: Docetaxel, Gemcitabine, Pemetrexed Disodium, Erlotinib Hydrochloride, Pembrolizumab
Study Phase: Phase 2
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 20, 2025
Intervention Type: Biological, Radiation
Study Drug: Cetuximab
Study Phase: Phase 3
GRECO-1: Phase I/II, Randomized, Placebo-Controlled Study of Stereotactic Body Radiation Therapy (SBRT) and GC4711 for Centrally Located or Large, Node-Negative Non-Small Cell Lung Cancer (NSCLC)
GRECO-1: Phase I/II, Randomized, Placebo-Controlled Study of Stereotactic Body Radiation Therapy (SBRT) and GC4711 for Centrally Located or Large, Node-Negative Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Terminated
Publish Date: April 30, 2024
Intervention Type: Drug
Study Drug: GC4711
Study Phase: Phase 1/Phase 2
An Open-Label, Proof of Concept, Efficacy, Safety and Tolerability Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Prevention and Treatment of Oral Mucositis Induced by Radiation Therapy
An Open-Label, Proof of Concept, Efficacy, Safety and Tolerability Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Prevention and Treatment of Oral Mucositis Induced by Radiation Therapy
Enrollment Status: Completed
Publish Date: November 19, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

5 Total Publications

Immunopipe: a comprehensive and flexible scRNA-seq and scTCR-seq data analysis pipeline.
Immunopipe: a comprehensive and flexible scRNA-seq and scTCR-seq data analysis pipeline.
Journal: NAR genomics and bioinformatics
Published: December 17, 2024
Similar Doctors
Distinguished in EGFR Positive Lung Cancer
Dr. Chi Zhang
Radiation Oncology
Distinguished in EGFR Positive Lung Cancer
Dr. Chi Zhang
Radiation Oncology

Mayo Clinic Arizona

13400 E Shea Blvd, 
Scottsdale, AZ 
 (14.3 miles away)
480-301-8000
Languages Spoken:
English, American Sign Language
See accepted insurances
Accepting New Patients
Offers Telehealth

Chi Zhang is a Radiation Oncologist in Scottsdale, Arizona. Dr. Zhang is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Acoustic Neuroma, Schwannoma, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Zhang is currently accepting new patients.

Advanced in EGFR Positive Lung Cancer
Dr. Lauren D. Stegman
Radiation Oncology
Advanced in EGFR Positive Lung Cancer
Dr. Lauren D. Stegman
Radiation Oncology

Arizona Digestive Health PC

4611 E Shea Blvd, Suite 120, 
Phoenix, AZ 
 (20.1 miles away)
623-547-2600
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lauren Stegman is a Radiation Oncologist in Phoenix, Arizona. Dr. Stegman is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC). Dr. Stegman is currently accepting new patients.

Advanced in EGFR Positive Lung Cancer
Dr. Terence T. Sio
Radiation Oncology
Advanced in EGFR Positive Lung Cancer
Dr. Terence T. Sio
Radiation Oncology

Mayo Clinic Arizona

13400 E Shea Blvd, 
Scottsdale, AZ 
 (14.3 miles away)
480-301-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Terence Sio is a Radiation Oncologist in Scottsdale, Arizona. Dr. Sio is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Posterior Fossa Tumor, and Small Cell Lung Cancer (SCLC). Dr. Sio is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Li's expertise for a condition
ConditionClose
      View All 20 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile